Chronic myeloid leukaemia: open trials in Japan

• NCT06788509

  A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

  Trial Treatment · Phase 1 · Janssen Research & Development, LLC

  National Hospital Organization Nagoya Medical Center, Nagoya · The Cancer Institute Hospital of JFCR, Tokyo

  Registry updated 2026-11-04

• NCT07354074

  Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP

  Trial Treatment · Phase 2 · Novartis Pharmaceuticals

  Fukuoka · Saitama · Yokohama

  Registry updated 2026-10-15

• NCT04925479

  Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia

  Trial Treatment · Phase 1/2 · Novartis Pharmaceuticals

  Osaka · Shinjuku Ku · Yokohama

  Registry updated 2026-09-25

• NCT06423911

  Study of Olverembatinib (HQP1351) in Patients With CML-CP

  Trial Treatment · Phase 3 · Ascentage Pharma Group Inc.

  Ehime · Kyoto · Okayama · Osaka · Sapporo · Sapporo · Tochigi · Tokyo · Tokyo · Tokyo · Yamagata · Yamanashi

  Registry updated 2026-09-15

• NCT04877522

  Asciminib Roll-over Study

  Trial Treatment · Phase 4 · Novartis Pharmaceuticals

  Kobe

  Registry updated 2026-07-06

• NCT06787144

  ELVN-001 for the Treatment of Chronic Myeloid Leukemia With and Without T315I Mutation in Japanese Participants

  Trial Treatment · Phase 1 · Enliven Therapeutics

  Akita University Hospital, Akita · Aiiku Hospital, Sapporo · Tokyo Medical University Hospital, Shinjuku-ku · The University of Osaka Hospital, Suita-shi

  Registry updated 2025-07-01

• NCT01281735

  International Chronic Myeloid Leukemia Pediatric Study

  Research · Poitiers University Hospital

  Keio University School of Medicine, Tokyo

  Registry updated 2024-01-17

All Chronic myeloid leukaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error